Scilex Holding Company (SCLX) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In USD
| Previous Close | 6.6 |
| Open | 6.82 |
| Day High | 6.88 |
| Day Low | 6.62 |
| 52-Week High | 21.34 |
| 52-Week Low | 2.62 |
| Volume | 100,041 |
| Average Volume | 169,356 |
| Market Cap | 56.59M |
| PE | -0.17 |
| EPS | -38.95 |
| Moving Average 50 Days | 6.59 |
| Moving Average 200 Days | 7.06 |
| Change | 0.07 |
Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets
GlobeNewswire Inc.
Jan 30, 2026 2:00 PM GMT
PALO ALTO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management product
Scilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property Counsel
GlobeNewswire Inc.
Jan 02, 2026 2:00 PM GMT
PALO ALTO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management product
Scilex Holding Company Confirms Dream Bowl 2026 Meme Coin Claim Process on December 24, 2025 Drop by Datavault AI Inc.
GlobeNewswire Inc.
Dec 23, 2025 2:00 PM GMT
PALO ALTO, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management product